These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 29326345

  • 1. microRNA-452 exerts growth-suppressive activity against T-cell acute lymphoblastic leukemia.
    Wang H, Guo Q, Zhu G, Zhu S, Yang P, Zhang M.
    J Investig Med; 2018 Apr; 66(4):773-779. PubMed ID: 29326345
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
    Qian L, Zhang W, Lei B, He A, Ye L, Li X, Dong X.
    Oncol Rep; 2016 Nov; 36(5):2511-2516. PubMed ID: 27666896
    [Abstract] [Full Text] [Related]

  • 7. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
    Liang X, Li Z, Men Q, Li Y, Li H, Chong T.
    Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
    [Abstract] [Full Text] [Related]

  • 8. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
    Cui J, Cheng Y, Zhang P, Sun M, Gao F, Liu C, Cai J.
    J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2.
    Jin J, Wang Y, Xu Y, Zhou X, Liu Y, Li X, Wang J.
    J Gene Med; 2017 Jun; 19(6-7):. PubMed ID: 27556228
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW, Wang J, Zhu MX, Wang YF, Yang SY, Ke XY.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1067-1073. PubMed ID: 30553455
    [Abstract] [Full Text] [Related]

  • 11. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X, Chen S, Xiu YL, Sun KX, Zong ZH, Zhao Y.
    Mol Cancer; 2015 Feb 04; 14(1):31. PubMed ID: 25649143
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma.
    Zhu FQ, Zeng L, Tang N, Tang YP, Zhou BP, Li FF, Wu WG, Zeng XB, Peng SS.
    Oncol Res; 2016 Oct 27; 24(6):415-427. PubMed ID: 28281962
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line.
    Podshivalova K, Wang EA, Hart T, Salomon DR.
    Leuk Res; 2018 Nov 27; 74():1-9. PubMed ID: 30269036
    [Abstract] [Full Text] [Related]

  • 15. miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways.
    Fang ZH, Wang SL, Zhao JT, Lin ZJ, Chen LY, Su R, Xie ST, Carter BZ, Xu B.
    Cell Death Dis; 2016 Sep 22; 7(9):e2371. PubMed ID: 27899822
    [Abstract] [Full Text] [Related]

  • 16. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
    Xiao R, Gan M, Jiang T.
    Hum Exp Toxicol; 2017 Nov 22; 36(11):1169-1176. PubMed ID: 27941168
    [Abstract] [Full Text] [Related]

  • 17. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ, Ren XY, He QM, Xu YF, Tang XR, Sun Y, Zeng MS, Kang TB, Liu N, Ma J.
    Cell Death Dis; 2015 Jan 22; 6(1):e1618. PubMed ID: 25611392
    [Abstract] [Full Text] [Related]

  • 18. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
    Wu WR, Sun H, Zhang R, Yu XH, Shi XD, Zhu MS, Zeng H, Yan LX, Xu LB, Liu C.
    Oncotarget; 2016 Apr 05; 7(14):18684-93. PubMed ID: 26919246
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.